TY - JOUR
T1 - In vitro and in vivo percutaneous absorption of seleno-L-methionine, an antioxidant agent, and other selenium species
AU - Lin, Chih Hung
AU - Fang, Chia Lang
AU - Al-Suwayeh, Saleh A.
AU - Yang, Shih Yun
AU - Fang, Jia You
PY - 2011/9
Y1 - 2011/9
N2 - Aim:To investigate the in vitro and in vivo percutaneous absorption of seleno-L-methionine (Se-L-M), an ultraviolet (UV)-protecting agent, from aqueous solutions.Methods:Aqueous solutions of Se-L-M were prepared in p H 4, 8, and 10.8 buffers. The p H 8 buffer contained 30% glycerol, propylene glycol (PG) and polyethylene glycol (PEG) 400. The in vitro skin permeation of Se-L-M via porcine skin and nude mouse skin was measured and compared using Franz diffusion cells. The in vivo skin tolerance study was performed, which examined transepidermal water loss (TEWL), skin p H and erythema.Results:In the excised porcine skin, the flux was 0.1, 11.4 and 8.2 gcm 2 h 1 for the p H 4, 8, and 10.8 buffers, respectively. A linear correlation between the flux and skin deposition was determined. According to permeation across skin with different treatments (stripping, delipidation, and ethanol treatments), it was determined that the intracellular route comprised the predominant pathway for Se-L-M permeation from p H 8 buffer. Aqueous solutions of seleno-DL-methionine (Se-DL-M), selenium sulfide and selenium-containing quantum dot nanoparticles were also used as donor systems. The DL form showed a lower flux (7.0 vs 11.4 gcm 2 h 1) and skin uptake (23.4 vs 47.3 g/g) as compared to the L form, indicating stereoselective permeation of this compound. There was no or only negligible permeation of selenium sulfide and quantum dots into and across the skin. With in vivo topical application for 4 and 8 h, the skin deposition of Se-L-M was about 7 g/g, and values were comparable to each other. The topical application of Se-L-M for up to 5 d did not caused apparent skin irritation. However, slight inflammation of the dermis was noted according to the histopathological examination.Conclusion:Se-L-M was readily absorbed by the skin in both the in vitro and in vivo experiments. The established profiles of Se-L-M skin absorption will be helpful in developing topical products of this compound.
AB - Aim:To investigate the in vitro and in vivo percutaneous absorption of seleno-L-methionine (Se-L-M), an ultraviolet (UV)-protecting agent, from aqueous solutions.Methods:Aqueous solutions of Se-L-M were prepared in p H 4, 8, and 10.8 buffers. The p H 8 buffer contained 30% glycerol, propylene glycol (PG) and polyethylene glycol (PEG) 400. The in vitro skin permeation of Se-L-M via porcine skin and nude mouse skin was measured and compared using Franz diffusion cells. The in vivo skin tolerance study was performed, which examined transepidermal water loss (TEWL), skin p H and erythema.Results:In the excised porcine skin, the flux was 0.1, 11.4 and 8.2 gcm 2 h 1 for the p H 4, 8, and 10.8 buffers, respectively. A linear correlation between the flux and skin deposition was determined. According to permeation across skin with different treatments (stripping, delipidation, and ethanol treatments), it was determined that the intracellular route comprised the predominant pathway for Se-L-M permeation from p H 8 buffer. Aqueous solutions of seleno-DL-methionine (Se-DL-M), selenium sulfide and selenium-containing quantum dot nanoparticles were also used as donor systems. The DL form showed a lower flux (7.0 vs 11.4 gcm 2 h 1) and skin uptake (23.4 vs 47.3 g/g) as compared to the L form, indicating stereoselective permeation of this compound. There was no or only negligible permeation of selenium sulfide and quantum dots into and across the skin. With in vivo topical application for 4 and 8 h, the skin deposition of Se-L-M was about 7 g/g, and values were comparable to each other. The topical application of Se-L-M for up to 5 d did not caused apparent skin irritation. However, slight inflammation of the dermis was noted according to the histopathological examination.Conclusion:Se-L-M was readily absorbed by the skin in both the in vitro and in vivo experiments. The established profiles of Se-L-M skin absorption will be helpful in developing topical products of this compound.
KW - percutaneous absorption
KW - selenium
KW - seleno-L-methionine
KW - skin
KW - topical delivery
UR - http://www.scopus.com/inward/record.url?scp=80052447465&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=80052447465&partnerID=8YFLogxK
U2 - 10.1038/aps.2011.89
DO - 10.1038/aps.2011.89
M3 - Article
C2 - 21785447
AN - SCOPUS:80052447465
SN - 1671-4083
VL - 32
SP - 1181
EP - 1190
JO - Acta Pharmacologica Sinica
JF - Acta Pharmacologica Sinica
IS - 9
ER -